Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000282143 | SCV000356679 | uncertain significance | Fumarase deficiency | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000373250 | SCV000356680 | uncertain significance | Hereditary leiomyomatosis and renal cell cancer | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000373250 | SCV000356681 | uncertain significance | Hereditary leiomyomatosis and renal cell cancer | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000455309 | SCV000539176 | uncertain significance | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Expansion of intronic repeat, unlikely to impact splicing. Other expansions near this position (maybe same one? Hard to tell) present in ExAC at moderate frequency (~0.1% E. Asian) |
Mendelics | RCV000282143 | SCV001135605 | likely benign | Fumarase deficiency | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001618510 | SCV001846017 | benign | not provided | 2019-08-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002365342 | SCV002664059 | likely benign | Hereditary cancer-predisposing syndrome | 2014-12-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001618510 | SCV004273566 | likely benign | not provided | 2024-01-07 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000455309 | SCV002568055 | likely benign | not specified | 2021-09-03 | no assertion criteria provided | clinical testing |